Concepedia
Statistics
Publications
6
Citations
496
H-Index
Active since
2013
Affiliations
AstraZeneca (United Kingdom)(Current)
AstraZeneca (United States)
AstraZeneca (Singapore)
AstraZeneca (France)
AstraZeneca (Germany)
Paula Taylor is an author at AstraZeneca (United Kingdom) specializing in oncology, pharmacology, and cancer pharmacology.
Publications per year
2013–2019
Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo
Susan Ashton, Young Ho Song, Elaine Cadogan et al. · Science Translational Medicine · 2016 · 220 citations
Pharmacy, Oncology, Pharmacology +17
Cells Lacking the <i>RB1</i> Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival
Matthew G. Oser, Raquel Fonseca, Abhishek A. Chakraborty et al. · Cancer Discovery · 2018 · 176 citations · Full text
Life Sciences, Genetics, Oncology +17
Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles
Nicolas Floc’h, Susan Ashton, Paula Taylor et al. · Molecular Cancer Therapeutics · 2017 · 36 citations · Full text
Medicine, Oncology, Pharmacology +13
Anti-tumour and anti-vascular effects of cediranib (AZD2171) alone and in combination with other anti-tumour therapies
Jane Kendrew, Rajesh Odedra, Armelle Logié et al. · Cancer Chemotherapy and Pharmacology · 2013 · 23 citations
Medicine, Oncology, Pharmacology +11
Modeling Dose and Schedule Effects of AZD2811 Nanoparticles Targeting Aurora B Kinase for Treatment of Diffuse Large B-cell Lymphoma
Nicolas Floc’h, Susan Ashton, Douglas Ferguson et al. · Molecular Cancer Therapeutics · 2019 · 22 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 6